Prospective study of adolescents with subsyndromal psychosis: Characteristics and outcome

Journal of Child and Adolescent Psychopharmacology

Volumn 15, Issue 3, 2005, Pages 418-433

  Correll, Christoph U ^a   Lencz, Todd ^a,b   Smith, Christopher W ^a   Auther, Andrea M ^a   Nakayama, Emilie Y ^a   Hovey, Lauren ^a   Olsen, Ruth ^a   Shah, Manoj ^a,b   Foley, Carmel ^a   Cornblatt, Barbara A ^a,b  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADOLESCENCE; ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; ASPERGER SYNDROME; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; COMORBIDITY; CONDUCT DISORDER; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MALE; MENTAL DISEASE; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; OUTCOMES RESEARCH; PERSONALITY DISORDER; PROSPECTIVE STUDY; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SCHIZOPHRENIA; SCHOOL CHILD; SUBSTANCE ABUSE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 23944442686     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2005.15.418     Document Type: Article

References (66)

1. Addington AM, Gornick M, Sporn AL, Gogtay N, Greenstein D, Lenane M, Gochman P, Baker N, Balkissoon R, Vakkalanka RK, Weinberger DR, Straub RE, Rapoport JL: Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol Psychiatry 55:976-980, 2004.
2. American Psychiatric Association: Task force on nomenclature and statistics. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington (DC), American Psychiatric Association, 1994.
3. Cornblatt BA: The New York high-risk project to the Hillside recognition and prevention (RAP) program. Am J Med Genet 114:956-966, 2002.
4. Cornblatt BA, Lencz T, Kane JM: Treatment of the schizophrenia prodrome: Is it presently ethical? Schizophr Res 51:31-38, 2001.
5. Cornblatt B, Lencz T, Obuchowski M: The schizophrenia prodrome: Treatment and high-risk perspectives. Schizophr Res 54:177-186, 2002.
6. Cornblatt B, Obuchowski M, Schnur D, O'Brien JD: Hillside study of risk and early detection in schizophrenia. Br J Psychiatry 172(Suppl):26-32, 1998.
7. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E: The schizophrenia prodrome revisited: A neurodevelopmental perspective. Schizophr Bull 29:633-651, 2003.
8. Correll CU, Kane JM: The psychotic prodrome: How effective are early interventions? Adv Schiz Clin Psych 1:2-10, 2004.
9. Cramer JA, Rosenheck R: Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 49:196-201, 1998.
10. Del Beccoro M, Burke MB, McCauley E: Hallucinations in children: A follow-up study. J Am Acad Child Adolesc Psychiatry 27:462-465, 1988.
11. Dhossche D, Ferdinand R, Van der Ende J, Hofstra MB, Verhulst F: Diagnostic outcome of self-reported hallucinations in a community sample of adolescents. Psychol Med 32:619-627, 2002.
12. Eaton W, Romanoski A, Anthony JC, Nestadt G: Screening for psychosis in the general population with a self-report interview. J Nerv Ment Dis 179:689-693, 1991.
13. Fennig S, Bromet EJ, Craig T, Jandorf L, Schwartz JE: Psychotic patients with unclear diagnoses. A descriptive analysis. J Nerv Ment Dis 183:207-213, 1995.
14. Fenton WS, McGlashan TH: Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course. Arch Gen Psychiatry 48:978-986, 1991.
15. Garralda ME: Hallucinations in children with conduct and emotional disorders. II: The follow-up study. Psychol Med 14:597-604, 1984.
16. Hollingshead AB: Two-factor index of social position. New Haven (Connecticut), Yale University, 1957.
17. Jorgensen P, Bennedsen B, Christensen J, Hyllested A: Acute and transient psychotic disorder: Comorbidity with personality disorder. Acta Psychiatr Scand 94:460-464, 1996.
18. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC: Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a U.S. community sample. The National Comorbidity Survey. Arch Gen Psychiatry 53:1022-1031, 1996.
19. Kendler KS, Walsh D: Schizophreniform disorder, delusional disorder, and psychotic disorder not otherwise specified: Clinical features, outcome, and familial psychopathology. Acta Psychiatr Scand 91:370-378, 1995.
20. Kumra S, Giedd JN, Vaituzis AC, Jacobsen LK, McKenna K, Bedwell J, Hamburger S, Nelson JE, Lenane M, Rapoport JL: Childhood-onset psychotic disorders: Magnetic resonance imaging of volumetric differences in brain structure. Am J Psychiatry 157:1467-1474, 2000.
21. Kumra S, Jacobsen LK, Lenane M, Zahn TP, Wiggs E, Alaghband-Rad J, Castellanos FX, Frazier JA, McKenna K, Gordon CT, Smith A, Hamburger S, Rapoport JL: "Multidimensionally impaired disorder": Is it a variant of very early-onset schizophrenia? J Am Acad Child Adolesc Psychiatry 37:91-99, 1998.
22. Kumra S, Sporn A, Hommer DW, Nicolson R, Thaker G, Israel E, Lenane M, Bedwell J, Jacobsen LK, Gochman P, Rapoport JL: Smooth pursuit eye-tracking impairment in childhood-onset psychotic disorders. Am J Psychiatry 158:1291-1298, 2001.
23. Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B: Nonspecific and attenuated negative symptoms in patients at clinical risk for schizophrenia. Schizophr Res 68:37-48, 2004.
24. Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B: The assessment of "prodromal schizophrenia." Schizophr Bull 29:717-728, 2003.
25. McClellan J, McCurry C: Early-onset psychotic disorders: Diagnostic stability and clinical characteristics. Eur Child Adolesc Psychiatry 8(Suppl 1): 113-119, 1999.
26. McClellan J, McCurry C, Snell J, DuBose A: Early-onset psychotic disorders: Course and outcome over a 2-year period. J Am Acad Child Adolesc Psychiatry 38:1380-1388, 1999.
27. McClellan J, Prezbindowski A, Breiger D, McCurry C: Neuropsychological functioning in early-onset psychotic disorders. Schizophr Res 68:21-26, 2004.
28. McGee R, Williams S, Poulton R: Hallucinations in nonpsychotic children. J Am Acad Child Adolesc Psychiatry 39:12-13, 2000.
29. McGlashan TH: Psychosis treatment prior to psychosis onset: Ethical issues. Schizophr Res 51: 47-54, 2001.
30. McGlashan TH, Miller TJ, Woods SW, Hoffman RE, Davidson L: Instrument for the assessment of prodromal symptoms and states. In: Early Intervention in Psychotic Disorders. Edited by Miller T, Mednick SA, McGlashan TH, Libiger J, Johannessen JO. Dordrecht, Netherlands, Kluwer Academic Publishers, 2001, pp 135-149.
31. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller TJ, Woods SW, Hawkins KA, Hoffman R, Lindborg S, Tohen M, Breier A: The PRIME North America randomized, double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr Res 61:7-18, 2003.
32. McGorry PD, Yung AR, Phillips LJ: The "close-in" or ultra high-risk model: A safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull 29:771-790, 2003.
33. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H: Randomized, controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 59:921-928, 2002.
34. McGorry PD, Yung A, Phillips L: Ethics and early intervention in psychosis: Keeping up the pace and staying in step. Schizophr Res 51:17-29, 2001.
35. McGorry PD, McFarlane C, Patton GC, Bell R, Hibbert ME, Jackson HJ, Bowes G: The prevalence of prodromal features of schizophrenia in adolescence: A preliminary survey. Acta Psychiatr Scand 92:241-249, 1995.
36. Menezes NM, Milovan E: First-episode psychosis: A comparative review of diagnostic evolution and predictive variables in adolescents versus adults. Can J Psychiatry 45:710-716, 2000.
37. Miller FT, Abrams T, Dulit R, Fyer M: Psychotic symptoms in patients with borderline personality disorder and concurrent axis I disorder. Hosp Commun Psychiatry 44:59-61, 1993.
38. Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, Woods SW: Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: Preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 159:863-865, 2002.
39. Moller HJ, Bottlender R, Wegner U, Wittmann J, Strauss A: Long-term course of schizophrenic, affective, a nd schizoaffective psychosis: Focus on negative symptoms and their impact on global indicators of outcome. Acta Psychiatr Scand 102(Suppl):54-57, 2000.
40. Murray RM, Sham P, van Os J, Zanelli J, Cannon M, McDonald C: A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 71:405-416, 2004.
41. Nicolson R, Lenane M, Brookner F, Gochman P, Kumra S, Spechler L, Giedd JN, Thaker GK, Wudarsky M, Rapoport JL: Children and adolescents with psychotic disorder not otherwise specified: A 2- to 8-year follow-up study. Compr Psychiatry 42:319-325, 2001.
42. Ohayon MM: Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res 97:153-164, 2000.
43. Pfohl B, Blum N, Zimmerman M: Structured Interview for DSM-IV Personality (SIDP-IV). Department of Psychiatry University of Iowa, 1995.
44. Pillmann F, Haring A, Balzuweit S, Marneros A: A comparison of DSM-IV brief psychotic disorder with "positive" schizophrenia and healthy controls. Compr Psychiatry 43:385-392, 2002.
45. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H: Children's self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study. Arch Gen Psychiatry 57:1053-1058, 2000.
46. Poyurovsky M, Kriss V, Weisman G, Faragian S, Kurs R, Schneidman M, Fuchs C, Weizman A, Weizman R: Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: Schizophrenic and OC symptoms in schizophrenia. J Clin Psychiatry 64:1300-1307, 2003.
47. Reimherr JP, McClellan JM: Diagnostic challenges in children and adolescents with psychotic disorders. J Clin Psychiatry 65(Suppl 6):5-11, 2004.
48. Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 56:241-247, 1999a.
49. Robinson DG, Woerner MG, Alvir JM, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Bilder R, Goldman R, Lieberman JA: Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 156:544-549, 1999b.
50. Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM: Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 161:473-479, 2004.
51. Sajith SG, Chandrasekaran R, Sadanandan Unni KE, Sahai A: Acute polymorphic psychotic disorder: Diagnostic stability over 3 years. Acta Psychiatr Scand 105:104-109, 2002.
52. Sattler JM: Assessment of Children: Cognitive Applications, 4th ed. La Mesa (California), Jerome M. Sattler, 2001.
53. Schulte-Markwort M, Schimmelmann BG: Differentiation between borderline personality disorder and schizophrenia. In: Childhood and Adolescent Psychosis. Edited by Burgin D, Meng H. Farmington (Connecticut), Karger Publishers, 2004, pp 109-114.
54. Schwartz JE, Fennig S, Tanenberg-Karant M, Carlson G, Craig T, Galambos N, Lavelle J, Bromet EJ: Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Arch Gen Psychiatry 57:593-600, 2000.
55. Susser E, Varma VK, Mattoo SK, Firmerty M, Mojtabai R, Tripathi BM, Misra AK, Wig NN: Long-term course of acute brief psychosis in a developing country setting. Br J Psychiatry 173: 226-230, 1998.
56. Susser E, Fennig S, Jandorf L, Amador X, Bromet E: Epidemiology, diagnosis, and course of brief psychoses. Am J Psychiatry 152:1743-1748, 1995.
57. Tien A: Distributions of hallucinations in the population. Soc Psychiatry Psychiatr Epidemiol 26: 287-292, 1991.
58. Ulloa RE, Birmaher B, Axelson D, Williamson DE, Brent DA, Ryan ND, Bridge J, Baugher M: Psychosis in a pediatric mood and anxiety disorders clinic: Phenomenology and correlates. J Am Acad Child Adolesc Psychiatry 39:337-345, 2000.
59. van Os J, Hanssen M, Bijl R, Ravelli A: Strauss (1969) revisited: A psychosis continuum in the general population? Schizophr Res 45:11-20, 2000.
60. van Os J, Hanssen M, Bijl RV, Vollebergh W: Prevalence of psychotic disorder and community level of psychotic symptoms: An urban-rural comparison. Arch Gen Psychiatry 58:663-668, 2001.
61. Verdoux H, Maurice-Tison S, Gay B, van Os J, Salamon R, Bourgeois M: A survey of delusional ideation in primary care patients. Psychol Med 28: 127-134, 1998.
62. Wechsler D: Manual for the Wechsler Adult Intelligence Scale-Revised. San Antonio (Texas), Psychological Corporation, 1981.
63. Wechsler D: Manual for the Wechsler Intelligence Scale for Children, 3rd ed. San Antonio (Texas), The Psychological Corporation, 1991.
64. Wolff S: 'Schizoid' personality in childhood and adult life. I: The vagaries of diagnostic labeling. Br J Psychiatry 159:615-620, 634-635, 1991.
65. Woods SW, Breier A, Zipursky RB, Perkins DO, Addington J, Miller TJ, Hawkins KA, Marquez E, Lindborg SR, Tohen M, McGlashan TH. Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry 54:453-464, 2003.
66. Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, Patton GC, Jackson HJ: Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry 172(Suppl):14-20, 1998.